RxDoctor Payments Data

Kyle Hardacker, MD

Orthopaedic Surgery · Providence, RINPI 1316505795

Payments from drug & device makers

What this record shows

9 manufacturers reported payments, led by Zimmer Biomet at 39.4% of the total. 2025 is the largest year on record at $3,796, more than ten times the $12 reported in 2019.

$7,714in general payments, 2019–2025

Across 85 payments — averaging $90.76 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Zimmer Biomet$3K
  • Medical Device Business Services, Inc.$2K
  • Stryker$760
  • Medtronic$754
  • Cerapedics Inc.$231
  • Globus Medical$227
  • plus $428 from 3 others

What the payments were for

  • Travel & lodging$3,12741%
  • Food & beverage$4,58759%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Zimmer Biomet40$3,043
Medical Device Business Services, Inc.10$2,272
Stryker19$760
Medtronic9$754
Cerapedics Inc.2$231
Globus Medical(2 entities)2$227
Acuity Surgical Devices, LLC1$205
Davol Inc.1$163
Blue Surgical LLC1$60

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$7,714 in reported general payments places this provider in the 60th percentile of 124 orthopaedic surgery providers in Rhode Island.

See all orthopaedic surgery providers in Rhode Island

Medicare billing

Part B allowed, 2024
$13,438
Medicare patients
51
Services billed
83

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Meloxicam12$17

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery in Providence

See the full list for Rhode Island

Where these figures come from

Is this you, or does something look wrong? →